Cancer is a diverse set of diseases with vastly different genotypes and phenotypes.
Cancer-specific biomarkers and their expression levels can vary considerably among different tumor types and within their growing endothelium. Our lab is currently investigating the functional role of different endothelial markers on tumor angiogenesis.
In understanding the basic molecular and cellular mechanisms that governs the tumor
angiogenesis, through this work, it would be helpful to design new therapeutic agents, more specifically new therapeutic targets.